Early Detection.
Brighter Futures.
The Signal Was Always There. Now We Can Read It.
Lumicede™ brings pancreatic cancer diagnosis into the endoscopy room — where it always belonged.
Lumicede™ is an adjunctive diagnostic platform that analyzes exosome biomarkers from duodenal-pancreatic fluid, collected seamlessly during routine EUS procedures. No extra steps. No additional procedures. Just clearer answers, sooner.
Our multidisciplinary team of clinicians, scientists, and engineers is rewriting the standard of care — bringing earlier answers to patients who can't afford to wait.
Interested in Lumicede™?
We welcome inquiries from clinicians, researchers, and organizations working in pancreatic cancer care and diagnostics.contact@lumicede.com